Background: Experience with the original protocols of the Association for the Advancement of Medical Instrumentation (AAMI) and the British Hypertension Society (BHS) for validating blood pressure has provided valuable insight into the methodological problems associated with device validation and has influenced both the BHS and the AAMl in revising their protocols. Objectives: To review the revisions of the original BHS and AAMl protocols; to compare the protocols; and, using the BHS protocol as a framework for validation, to determine how it should be modified to a protocol that will fulfil the criteria of both the AAMl and the BHS. Conclusions: The revised protocols have many similarities but there are some important differences. These differences merit consideration so as to facilitate manufacturers seeking to validate devices for acceptance in both Europe and the United States. Of the two protocols, the BHS protocol is the more elaborate in that ( 1 ) it takes particular care to ensure that observers are trained to a very high standard, (2) it makes provision for special group validation and (3) it recommends in-use validation of all devices. By modifying the BHS protocol, it is possible to validate blood pressure measuring devices (ambulatory devices require special consideration) to satisfy the criteria of both protocols.
Introduction
T h e problelii of device inaccuracy, which was wellrecogtiized ill the early days of spliyg~nomanometry [I] , has been voiced strongly in recent years by hypertension researchers, as show11 by the growing nuniber of publications 011 the subject [2] . In the 1960s and 1970s individual groups, frustrated by the failure of nianufacturers to produce evidence of accuracy to rliatcli their clainis for device perforliiance, began to validate blood pressure l~ieasurilig systems according to a variety of protocols and so illustrated the need for indeperiderit device validation [3-61. However well-intentioned such protocols lilay have been, they had the serious disadvantage of not perliiittil~g coniparison of one device with another because of the differing riiethodologies of validation [7] . In 1986, the Associatioli for the Advancement of Medical I~istruliientatioli (AAMl) published a stalidard for automated blood pressure ~neasurit~g devices that included a protocol for the evaluatiori of device accuracy [8] . This was followed in 1990 by the protocol of the British tlypertelisioli Society (BHS) [9] . Tliese protocols, which differed in detail, had a conimon objective: the standardization of validation to establish nlinil~lum standards of accuracy and performance and to Licilitate conlparison of one device with another [lo] . These two protocols, both of which have been revised recently [I 1-14] , are likely to govern the effective procedures for device validation for the next few years. Although the protocols have niariy similarities, there are differences of considerable practical importance to niariufiicturers who nlay wish to have their equipriient validated according to criteria acceptable to both the European and the A~~lericari markets. O f tlie two, the BHS protocol is niore elaborate than the AAMI protocol ill that it takes particular care to ensure that observers are trained to a very high standard, it ~nakes provision for special group validation and it reconiniends in-use valiclatioii of all devices. Unlike the AAMI protocol, which has been adopted as a riatiollal standard, the BIHS protocol does not address nianuficturing recluire~iiel~ts or recoliinielld ilitra-arterial coiiiparisol~ (an optional test in the AAMI protocol). This paper has three ailils: first, to review briefly the espericllce gained with the original BHS and AAMI protocols that has influenced the changes nlade in the revised protocols; second, to conipare one protocol with the other; and, finally, ilsing the BHS protocol as a fraliiework for validation, to deterii~ine how it shoiild bc ~iiodifictl so as to dcvisc a protocol that will frllfil the criteria of both the AAMI and the UHS.
Experience with the AAMI and BHS protocols
Silicc tlic AAMl standard was first published in 1987 a nu~nbcr of devices have been validated accordillg to its recolii~lielidatiolis and the AAMI criteria for accuracy have been applied to a number of validations perfbrllicd according to the 13HS protocol [20-321. Since the UIHS protocol was first published in 1990 it has been applied to the cvaluatioll of eight ailibulatory systelns 281 . Additionally, the BHS protocol, either ill its entirety o r partially, has been used to evaluate seven Jrviccs of self-llicasure~iicl~t of blood pressure [29] , the Hawkslcy randorii zero spliygmo~~ia~~oliieter [30] , and the Dinanlap 8100 1311. T h e collective experience with these protocols has illustrated sollie niajor aspects of validation tliat were riot apparent when the protocols were origillally drawn up.
The importance of indicating device modification
The original BHS protocol eniphasized the ililportance of ~~ianufncturers indicating by a change ill niodcl ~iuiii-bcr any ~llodifications niade to blood pressure nieasuring devices [Y] . The ilnportance of this stricture is wellillustrated by the conflicting reports froni a number o f laboratories o n the accuracy of the Takeda TM-2420 [15-19,25,27,32] , many of which uscd the AAMI or 13HS validation procedures. T h e results of the individual studies on this device, which have been reviewed in detail elsewhere [33] , show that apparent differences between laboratories can be accounted for by different models being submitted for validation by the nianufacturers without the users being aware that ~nodifications may have been nude to the device. This trend has hopefully passed, and it is perhaps significant that the two latest reports on the Takeda stipulate the version being tlscd [18, 20] .
Another exaniple of device n~odification affecting accuracy is that reported by Hansen arid Orskov [34] , who observed apparently inexplicable variations in niean arterial blood pressure in a longitudinal study, which were incolisistent with the observed changes ill systolic and diastolic blood pressure. It becanie apparent that the software progranis of the SyaceLabs 90202 nionitors used at the beginning of the stiidy had bee11 updated by the ~iianuL~cturer when the nionitors were repaired. Also, liew devices supplied by the nlariiifacturers during the study, though ostensibly the saiiie 90202 niode, also contained the updated software. T h e con~pany readily adlilitted that it had ~nodified the software program for liiean arterial pressure in the interests of greater accuracy and that the ll~odification had resulted in liiean arterial pressure being 3-4 niniHg higher with the new program, but they had not disclosed this to the user [34] .
The iliiportance of device lnodification is also illustrated ill the evaluation of the Profiloniat alnbulatory systelii [21] . The Profilomat was developed for use in general practice by liiodifYing the more expensive and elaborate CH-Druck a~nbulatory system [20] . Duriiig validatioli it bccanie evident that the Profiloniat was providing fewer valid measurenlents during ambulatory use than the pare l~t CH-Druck, because the facility for repeating measurenients ill the event of a failed nieasuren~ent had been removed; when it was replaced the niodified recorders conifortably fulfilled the protocol requirements [21] .
T h e revised BHS protocol eniphasizes, therefore, that it is incunibent upon nlanufacturers to indicate clearly all nlodificatioas in the technological and software conipolielits of autonlated devices by changing the device 1111111-ber. Furtherli~ore, modified devices nus st be subjected to renewed validation [ I 41 .
The effect of blood pressure level on device accuracy
During the validation of six anibulatory devices in our laboratory [20-251, a tendency was noted for accuracy to deteriorate with increasing levels of blood pressure [35] . When the data were analysed according to tertiles of pressure for low, ~~i c d i u~n and high pressure ranges all six devices held their overall grading, or improved the111 slightly ill the low arid nlediun~ pressure ranges, but in the high pressure range the devices lost accuracy. A similar tendency has also been reported by Pannarale and colleagues for oscillonletric iileasurenlent [36] .
T h e revised BHS protocol reconiinends, therefore, that the validation analysis should be performed not alone for the overall pressure range but also according to tertiles of pressure 1141.
The effect of age on device accuracy Miller and colleagues [37] have observed that discrepancies between an ambulatory device and nlercury standard were systeniatically related t o characteristics of the study participants, such as age, sex and race, with age denionstrating the strongest correlation. Clark and colleagues [38] have noted a tendency for anibulatory systelris, especially those using the oscillonietric technique, to be less accurate in the elderly. These results suggest that an~bulatory systenls for use in the elderly should be evaluated specifically in an aged population and that the effects of age and blood pressure level 011 accuracy sliould be exalliilied carefully [39] .
Uotli revised protocols acknowlecigc the influelice of age on the accuracy of blood pressure nieasurenient and the UHS protocol has a special group validation procedure for devices tliat l~iiglit be used particularly in the elderly.
The importance of in-use testing
To overcon~e the probleni of devices losillg accuracy 1111-der the stress of everyday use, the BHS protocol stipulates that validation should take place only after die device has hat1 a reasonable period of use [14] . This test serves a liuniber of furictioiis. First, devices liiay C.il to function durillg tlie in-use phase [29] anci it woulrl be clearly wastefill of resources to proceed to the ~iiain validation procedure with such a device. The test serves, therefore, as all illdicator of the ability of the device to stand up to tlie stresses of everyday use. The value of tlie iri-use pllasc ill liighlighti~~g i~iadeq~~acies in tlie device that niay be anieliable to easy correctioli by the manufacturers has been illustrated by the account cited above of the ProGlolliat having had the facility for a repeat Inensuremerit reliloved in the interests of reducing the cost of the device [21] . The period of use also perlilits sollie expression by the user as to the ease of use and collifort of the device, and so~iietiilles useful reconiliiendations call be lliade to the nianufacturer that result in iniproved ecluipl~ient [20-251.
The UHS protocol retains the ill-use phase in the revised version [14] and tlie AAMI protocol has incorporated an in-use phase for devices measuring anibulatory blood pressure [12] .
lrnportance of adhering to the protocols The ilnportalice of adhering nieticulously to the AAMI or I3HS protocols is that devices validated with the protocols call be coliipared. However, if the protocols are ~nodified such coniparisons are not possible. Tliis arises, for exaliiple, ill two validation studies in pregnancy 120,401 in which tlie protocols were niodified by substi-;utillgtlie Hawksley randoni zero sphyglliol~ia;iomcter for tlie standard mercury sphygiiol~laliolrieter stipulated in both the AAMI 2nd BHS protocols [8, 9] . The inaccuracy of aliibulatory devices in detecting diastolic blood pressure in pregnancy noted in these studies must be viewed critically as the comparative standard (the Hawkslcy) has itself been show11 to be inaccurate [30] . 
Comparison of the revised BHS and AAMI validation protocols

Can the AAMI and BHS protocols be reconciled?
O f the two protocols, the BHS protocol is the niore elaborate in that it takes particular care to ensure that observers are trained to a very high standard, it n~akes provision for special group validation and it reconlniends in-use validation of all devices [14] . It does not recommend intra-arterial comparison, an optional test in the AAMI protocol [12] . Taking the BHS protocol as a framework for validation, how should it be niodified so that it n~eets the AAMI criteria as well? To answer this question it is necessary to consider separately devices designed for li~easurilig blood pressure in static conditions (the majority of devices) and those designed specifically for nieasurilig a~nbulatory blood pressure.
Devices for static measurement
Phase I (before-use device calibration), Phase 11 [ill-use (field) assesslrient] and Pliase I11 (after-use device calibration) can be conducted without change, as in the revised BI-IS protocol [14] . Phase IV (static device validation) should be conducted as published but the following additional features sho~lld be included to coniply with the AAMI protocol.
Participant selection
The BHS protocol allows a distribution of study participants with a range of arrn circunlferences by chance, whereas the AAMI stipulates that 10%) of participants should have an arlli circumference less than 25 cnl and 10%) all arni circuliiference greater than 35cm. Both protocols reconinlend tliat participants should be above or below siniilar liniits of blood pressure, but the AAMI standard states this in percentages and the BHS protocol in absolute riunibers. In practice this nieans that to coniply with both protocols nine participants (rather than at least eight as in the BHS protocol) should have pressures ill each of the following categories: systolic blood pressure > 180 and < 100 ~ilniHg; diastolic blood pressure > 100 and < 60 1nniH.g. .,
Measurement to the nearest 1 mmHg
Measurenlerits should be taken to the nearest I niniHg rather than to the nearest 2 mnlHg. As this lnodification is, in theory at least, Inore accurate than measuring to the nearest 2 n l n~H g it will not be necessary also to measure to the nearest 2nimHg, as recomrnended in the BHS protocol. It should be borne ill n i i~~d that the niarkings at 2 nilnHg intervals on most mercury spliygtnomanonieters are likely to bias an observer towards rounding measureliients to the nearest 2 mmHg.
Sequential versus simultaneous same-arm measurements
Both revisions of the protocols stipulate that oppositearm coniparisotis should not be perfornled because of the probleni of inter-arn~ difference. The revised BHS protocol reconinlends only a sequential same-an11 test. However, the sequence of nieasureliient stipulated in tlie BHS protocol [14] can be niodified if the inflation niechanisnl of the device pernlits siniultaneous comparison using the following sequence, which merely requires the observers to nleasure additional pressures during the ~neasure~nent of the test instrument at blood pressure co~llparisons 2, 4 and 6 (Table 2) .
This sequence provides the data necessary for analysis by both the sequential and the si~nultaneous techniques, thereby fulfilling the requirelnents of both protocols.
Accuracy criteria 111 addition to grading the test device according to the BHS accuracy criteria, the accuracy criteria ofthe AAMI and a percentage grading can be applied to the data (Table 1) .
Devices for ambulatory measurement
The requirements denlanded for validating devices for static ~neasure~~lent also apply to those for measuring blood pressure under arl~bulatory conditions, but other considerations nlust also be given attention. Both revisions of the BHS and AAMI protocols acknowledge that if the anlbulatory system being evaluated has been designed to nleasure blood pressure inter~nittently during the 24-h period when the participant has been instructed to cease activity and to keep the arm still during measurement, the static validation test is all that is required. Both protocols stipulate, however, that the anlbulatory systenl must be subjected to an in-use assessment and that calibration should be tested after use. The revised BHS protocol acknowledged that the recommendations made From [ I 41. in tlie original protocol for recordings every 15 niiii during the day had proved onerous for participants and ill the revised protocol 30-lilin ilitervals are stipulated for the day 2nd night-time periods. However, the revised AAMI protocol adopts the original BHS requirelnent of 15-illill ilitervals during tlie day. Both protocols stipulate tliat thrcc dcvices slioulcl bc tcstcd but the requirelllcl~t for thc AAMI is for 30 24-11 studies in 10 participants and the BHS requireiiiellt is for 24 24-h studies in 24 participalits, half of wlioni should be ~iorniotensive and half hypertensive. To comply with both protocols, therefore, it will be necessary to increase the liuniber of 24-h studies in the BHS protocol Goni 24 to 3 0 and to increase the day-time recordings froni 30-to 15-inin intervals. Both protocols acknowledge that posture liiay affect accuracy. T h e revised BHS protocol recotiilnends that ambulatory systena be subjected to testing for posture in a subgroup of 30 participants in the standing, supine and sitting positions. The revised AAMI protocol stipulates that a fill1 validation be perfornied in the supine, sitting and standii~g positioiis so that there are 765 paired ~rieasurcnlcnts for analysis. This stipulation assumes that the device can be validated by simultaneous conlparison, whereas our experience is that most devices cannot be validated in this way because of their inflation/deflatioli characteristics. Because of this the BHS protocol niakes provisioil only for sequential conlparison. We believe that the AAMl requirement for full validatioti in three positions in 8 5 participants will be practical, albeit at a high cost, only for the few devices suitable for simultalieous conlparison, and that it will be inlpractical for devices requiring sequential conlparison. At this stage we call ollly alert nlanuhcturers of anibulatory syste~ns to this serious problelii and suggest that the decision as to which protocol to follow should be based on a nul~lber of considerations, not least of which would be the feasibility of performing siniultai~eous comparison.
Finally, the revised BHS protocol reconlnlends a noninvasive assesslilent during exercise for anlbulatory systems that claiin accuracy durilig motion [14] . T h e revised AAMI protocol reconimends corrlparison ill opposite arms using direct intra-arterial nieasurenlent either during bicycle exercise with standard intra-arterial tcchniques o r during aliibulatory activity using the Oxford system to provide continuous recordilig [12] . T h e I3HS protocol does not advocate intra-arterial testing [14] , and though this is included in the AAMI protocol, it is not liia~idatory [12] . Moreover, both revised protocols rcconnilend that opposite-arni colilparisoiis should not be used because o f inter-ariil differences.
in sumnlary, the following nlodifications to the BHS protocol will fulfil the criteria of both tlie revised BHS and AAMI protocols for all blood pressure measuring devices:
(1) consideration of arm circuli~ference and liniits of blood pressure in participant selection (Table 1) ; (2) nieasurenlent to the nearest 1ililnHg in the main validation test; (3) sequential and siillultaneous (when feasible) comparison using the sequence outlined in Table 2 ; (4) analysis to include the AAMI accuracy criteria of iriean difference 1 5 nimI-lg with standard deviation of differences 1 8 mmHg, and 95% of device nleasurements within 1 0 mlnHg and 85% within 5 liiliiHg for systolic and diastolic blood pressures; (5) for ambulatory devices, the number of 24-h studies to be increased froni 24 to 3 0 and the daytime recording intervals from 30 to 1 5 min; careful consideration has to be given to the choice of validation procedure.
